🎯Oncology (General)
Cancer-focused biotechs developing novel therapies including immunotherapies, targeted therapies, and combination treatments.
Market Cap$236.6B
1D-1.72%
Companies952
Public Cos86
SECTOR MARKET CAP
$236.6B+8188.5%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $28.1B | ONC |
| 2 |  | United States | $19.0B | RVMD |
| 3 |  | China | $17.8B | 1801.HK |
| 4 |  | China | $16.3B | 688506.SS |
| 5 |  | Denmark | $15.4B | GMAB |
| 6 |  | France | $14.2B | IPN.PA |
| 7 |  | United Kingdom | $12.0B | SMMT |
| 8 |  | United States | $10.7B | EXEL |
| 9 |  | China | $8.3B | 002653.SZ |
| 10 |  | Japan | $7.7B | 4151.T |
| 11 |  | United States | $6.9B | NUVL |
| 12 |  | United States | $6.7B | ACLX |
| 13 |  | United States | $5.5B | CGON |
| 14 |  | United States | $5.3B | TERN |
| 15 |  | United States | $5.2B | CAI |
| 16 |  | United States | $4.9B | LNTH |
| 17 |  | Finland | $2.5B | ORNAV.HE |
| 18 |  | United States | $1.7B | ELVN |
| 19 |  | United States | $1.5B | NRIX |
| 20 |  | United States | $1.5B | NUVB |